Development of a bispecific nanobody conjugate broadly neutralizes diverse SARS-CoV-2 variants and structural basis for its broad neutralization
Jing Yang(Guizhou University), Guangwen Lu(Sichuan University), Keqing Yin(Sichuan University), Haohao Dong(Sichuan University), Chongzhang Yu(Sichuan University), Honglu Sun(Sichuan University), Bin He(Guiyang Medical University), Yushan Dai(Sichuan University), Xindan Zhang(Xinjiang University), Fanli Yang(Sichuan University), Zimin Chen(Sichuan University), Lingling Wang(SLAC National Accelerator Laboratory), Jian Li(Beijing Normal University), Bo Chen(Capital Medical University), Yu Cao(Sichuan University), Sheng Lin(Guangzhou Medical University), Yanping Duan(Sichuan University), Xianbo Liu, Qi Zhao(Northwest A&F University), Xin Yuan(Sichuan University), Liyan Guo(Sichuan University), Haoyu Ye(Sichuan University)
Cited by 16
Related Papers
Sirt5 Is a NAD-Dependent Protein Lysine Demalonylase and Desuccinylase
|Science|2011|1.4k
Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26
|Nature|2013|756
SARS-CoV-2 M <sup>pro</sup> inhibitors with antiviral activity in a transgenic mouse model
|Science|2021|449
Overview of lethal human coronaviruses
|Signal Transduction and Targeted Therapy|2020|312